Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185913 · ClinicalTrials.gov registry record
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 50
- Enrollment target
NCT00185913: Completed study, sponsored by Stanford University.
NCT00185913 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185913 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2000-09 |
| Est. Completion | 2008-05 |
What the finished NCT00185913 record still lists
NCT00185913 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00185913 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00185913 about?
NCT00185913 is a clinical study titled "Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers". The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
What is the current status of trial NCT00185913?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2000-09. Estimated completion is 2008-05.
Who is sponsoring clinical trial NCT00185913?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia